NATICK, Mass. and MIAMI , Jan. 16, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the ...

NATICK, Mass. , Jan. 3, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) is scheduled to participate in the 30th Annual J.P. Morgan Healthcare Conference in San Francisco . Hank Kucheman ...

This medical device maker recently raised full year guidance after a Q2 earnings beat.

Recently, we upgraded Boston Scientific Corporation to Outperform with a target price of $7.75.

NATICK, Mass., Jan. 3, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Neurovascular business to Stryker Corporation. The sale price is $1.5 billion, of which $1.45 billion was received at closing (including an upfront payment of $1.376 billion, a $50 million milestone payment associated with the commercialization of the next ...